Jack Higgins - 23 Jul 2026 Form 4 Insider Report for Immunome Inc. (IMNM)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
27 Jul 2026, 16:10:12 UTC
Prior SEC filing
03 Apr 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Sandra Stoneman, Attorney-in-Fact

Key filing fact

Jack Higgins filed Form 4 for Immunome Inc. (IMNM) on 27 Jul 2026.

Key facts

  • This page summarizes Jack Higgins's Form 4 filing for Immunome Inc. (IMNM).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 27 Jul 2026, 16:10.

Change

  • Previous filing in this sequence was filed on 03 Apr 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001993684 Primary reporting owner

Higgins Jack

Relationship
Chief Scientific Officer
Address
C/O IMMUNOME, INC., 18702 N. CREEK PARKWAY, SUITE 100, BOTHELL
Signature
/s/ Sandra Stoneman, Attorney-in-Fact
Signature date
27 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

IMNM transaction

Common Stock

Award

Transaction value
Shares
+38,250
Change %
+174%
Price
$0.000000*
Shares after
60,250
Date
23 Jul 2026
Ownership
Direct
Footnotes
F1
IMNM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,000
Date
23 Jul 2026
Ownership
As Custodian for Child 1
Footnotes
F2
IMNM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,000
Date
23 Jul 2026
Ownership
As Custodian for Child 2
Footnotes
F2
IMNM holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,000
Date
23 Jul 2026
Ownership
As Custodian for Child 3
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IMNM transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
Shares
+76,500
Change %
Price
$0.000000*
Shares after
76,500
Date
23 Jul 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
76,500
Exercise price
$22.01
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents the number of shares of the Issuer's common stock ("Common Stock") underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of Common Stock upon settlement. 25% of the RSUs will vest and settle into Common Stock annually on each anniversary of the grant date, subject to the Reporting Person's continuous service through each such vesting date.

Footnote F2

The Reporting Person serves as a custodian of a custodial account for his child pursuant to the Uniform Transfer to Minors Act. The Reporting Person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 or for any other purpose.

Footnote F3

25% of the shares subject to the options vest on July 23, 2027, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter, subject to the Reporting Person's continuous service through each such vesting date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .